Strong Patents: Lip Service vs. True Commitment

Every biotech CEO says it.

“We are committed to strong patents.”

But here’s the uncomfortable truth: words don’t build patent fortresses. Budgets do.

The question that separates talk from true commitment is simple:

👉 What percentage of your R&D budget is dedicated to experiments requested by your patent team to strengthen and broaden patents?

If the answer is $0, or “we don’t really track that,” then your company may be more vulnerable than you realize. Without patent-strengthening data, portfolios can collapse in prosecution, fall apart under diligence, or get invalidated in litigation.

At Double Helix Law, we work with biotech leaders to ensure their IP teams proactively guide experiments that support broader claims to block design-arounds, and build true competitive fortresses.

🔗 Read our full "Commitment vs. Lip Service" blog post for much more insight

---

About DHL

Double Helix Law (DHL) has decades of experience building strong patent portfolios for life science companies. Learn more about DHL and meet the team.

Want to stay updated on life science patent law? Subscribe to get notified of updates

 The content on this website (including all pages, articles, and comments) is not legal advice, and does not and is not intended to form or constitute any attorney-client relationship. The content is not a solicitation for business; it is for educational and entertainment purposes only, and reflects the personal views of the author(s) only and not those of any past, present, or future client of DHL. Any content should be double-checked for accuracy and current applicability, and liability is disclaimed for any error or omission.

9/25/25 Published (EJV)